Jacob A. Orville - Feb 23, 2022 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Signature
/s/ Jacob A. Orville by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Feb 23, 2022
Transactions value $
-$330,662
Form type
4
Date filed
2/25/2022, 05:31 PM
Previous filing
Feb 24, 2022
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $0 +10.2K +106.7% $0.00 19.8K Feb 23, 2022 Direct F1
transaction EXAS Common Stock Sale -$331K -4.72K -23.88% $70.10 15K Feb 24, 2022 Direct F2, F3
holding EXAS Common Stock 312 Feb 23, 2022 Held in 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Performance Stock Units Options Exercise $0 -10.2K -100% $0.00* 0 Feb 23, 2022 Common Stock 10.2K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit award.
F2 Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units on February 23, 2022.
F3 In addition to the shares of Common Stock reported on this Form 4, which total 15,349 shares, Mr. Orville also holds, in the aggregate, an additional 21,035 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F4 Each Performance Share Unit represents a right to receive one share of common stock.
F5 The PSU Award was subject to certain performance-based vesting requirements for the three-year period ending December 31, 2021.